on EnVVeno Medical Corporation (NASDAQ:NVNO)
EnVVeno Medical Featured in Virtual Investor Conference
enVVeno Medical Corporation, based in Irvine, California, announced its participation in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference. CEO Rob Berman highlighted his dedication to the company and discussed the development of enVVeno's products.
Participants can access the on-demand video webcast at virtualinvestorco.com and the company's website. enVVeno, listed on NASDAQ as NVNO, is advancing solutions for deep venous disease with their products VenoValve® and enVVe®. These innovations are aimed at treating Chronic Venous Insufficiency (CVI) by acting as one-way valves to aid blood flow.
The VenoValve® is undergoing a pivotal study, while enVVe® is in final testing stages for trial approval.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EnVVeno Medical Corporation news